Eleven Biotherapeutics, Inc.
Eleven Biotherapeutics, Inc. (EBIO) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 138 transactions totaling $15.0M, demonstrating a bearish sentiment with -$3.0M in net insider flow. The most recent transaction on Feb 14, 2017 involved a sale of 1,399 shares valued at $2.9K.
EBIO Insider Activity Summary
Who Is Buying EBIO Stock?
No significant insider buying has been recorded for EBIO in the recent period.
Who Is Selling EBIO Stock?
No significant insider selling has been recorded for EBIO in the recent period.
Is Eleven Biotherapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for EBIO is bearish with an Insider Alignment Score of 40/100 and a net flow of -$3.0M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
EBIO Frequently Asked Questions
Understanding EBIO Insider Activity
Insider trading at Eleven Biotherapeutics, Inc. (EBIO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading EBIO stock, having executed 138 transactions in the past 90 days. The most active insider is Edwin M. Kania Jr (Executive), who has made 14 transactions totaling $5.2M.
Related Tools
Track Eleven Biotherapeutics, Inc. Insider Activity
Get notified when executives and directors at EBIO file new Form 4 transactions